08/16/22 7:00 AMNasdaq : SCTL Societal CDMO Announces Signing of More Than $9 Million Sales and Purchase Agreement With David Weekley Homes for Excess Lakefront LandEstablished Homebuilder to Purchase Approximately 121 Acres in Gainesville, Georgia, for Residential Development Proceeds from Sale to Strengthen Societal CDMO’s Corporate Balance Sheet Through Planned Debt Reduction; Second Real Estate Transaction in Process to Further Enhance Financial PositionRHEA-AIneutral
08/10/22 4:05 PMNasdaq : SCTL earningsSocietal CDMO Reports Second Quarter 2022 Financial ResultsRecorded Q2 Revenue of $23.2 Million, a 29% Increase Compared to Prior Year Period Signed Multiple New Business Agreements Spanning Clinical Trial Support, Commercial Manufacturing and Packaging Launched Innovative “20/80 Second Source Technical Transfer” Program; New Model Offers IncreasedRHEA-AIneutral
08/04/22 7:00 AMNasdaq : SCTL clinical trialSocietal CDMO Adds Three New Customers, Signing Agreements to Provide CDMO Services Supporting Clinical Development of Several Novel Therapeutic CandidatesRHEA-AIneutral
08/03/22 4:05 PMNasdaq : SCTL conferencesearningsSocietal CDMO to Report Financial Results for Second Quarter 2022 on August 10, 2022Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solvingRHEA-AIneutral
07/20/22 7:00 AMNasdaq : SCTL clinical trialSocietal CDMO Selected To Provide Tech Transfer And Manufacturing Services To Support Clinical Development Of An Oral Solid Dose Product In EuropeSocietal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO)RHEA-AIneutral
07/12/22 7:00 AMNasdaq : SCTL Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR ProductsSocietal CDMO, Inc. (“Societal CDMO”; NASD:RHEA-AIpositive
07/07/22 4:05 PMNasdaq : SCTL Societal CDMO Reports Inducement Grants for New StaffSocietal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeuticRHEA-AIvery positive
06/08/22 7:00 AMNasdaq : SCTL Societal CDMO Announces Key New Customer Project Within Automated Fill/Finish and Lyophilization Unit at San Diego FacilitySocietal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), aRHEA-AIneutral
06/01/22 7:00 AMNasdaq : SCTL clinical trialSocietal CDMO Selected By AmyriAD Pharma to Provide Clinical Trials Services to Support Pivotal Phase 3 Program For Alzheimer’s Disease Treatment, AD101Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO)RHEA-AIpositive
05/19/22 7:00 AMNasdaq : SCTL conferencesSocietal to Participate in Upcoming Investor ConferencesSocietal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small moleculeRHEA-AIneutral